Citrato y calculos renales - Calculos Renales Ecuador. No Mas ...

12. Nicar, M. J.; Peterson, R.; Pak, C. Y. C.: Use of potassium citrate as potassium suplement during thiazide therapy of calcium nephrolithiasis.
J. Urol. 131: 430-433 (1984).
13. Pak, C. Y. C.; Skurla, C.; Brinkley, L.; Sakhaee, K.: Augmentation of renal citrate excretion by oral potassium citrate administration: time
course, dose frequency Schedule, and dose-response relationship. J. clin. Pharm. 24: 19-26 (1984).
14. Sakhaee, H.; Nicar, M.; Hill, K.; Pak, C. Y. C.: Contrasting eects of potassium citrate and sodium citrate therapies on urinary chemistries and
crystallization of stone-forming salts. Kidney int. 24; 348-352 (1983).
15. Preminger, G.,; Sakhaee, H.; Skurla, C.; Pak, C. Y. C.: Prevention of recurrent calcium stone formation with potassium citrate therapy in
patients with distal renal tubular acidosis. J. Urol. 134: 20-23 (1985).
16. Pak, C. Y. C.; Peterson, R.; Sakhaee, K.; Fuller, C.; Preminger, G.; Reisch, J.: Correction of hypocitraturia and prevention of stone formation
by combined thiazide and potassium citrate therapy in thiazide unresponsive hypercalciuric nephrolithiasis. Am. J. Med. 134: 11-19 (1985).
17. Pak, C. Y. C.; Fuller, C.; Sakhaee, K.; Preminger, G.; Britton, F.: Long-term treatment of calcium nephrolithiasis with potassium citrate. J. Urol.
134: 11-19 (1985)
18. Yendt, F.R.; Cohanim, M.: Prevention of calcium stones with thiazides. Kidney int. 13: 397-409 (1978).
19. Kassirer, J. P.; Berkman, P. M.; Lawrenz, D.R.; Schwartz, W. B.: The critical role of chloride in the correction of hypokalemic alkalosis in man.
Am. J. Med. 38: 172-189 (1965).
20. Pak, C. Y. C.: Renal calculi in Wyngarden, Smith, Plum, Cecil textbook of medicine. 89th ed. pp. 628-633 (Saunders, Philadelphia 1985).
21. Pak, C. Y. C.; Britton, F.; Peterson, R.; Ward, D.; Northcutt, C.; Brestau, N. A.; McGuire, J.; Sakhaee, K.; Bush, S.; Nicar, M.; Norman, D. A.;
Peters, P.: Ambulatory evaluation of nephrolithiasis. Classication, clinical presentation and diagnostic criteria. Am. J. Med. 69: 19-30 (1980).
22. Hosking, D. H.; Ericsson, S. B.; Van der Berg, C. J.; Wilson, D. M.; Smith, L. H.: The stone clinic eect in patients with idiopathic calcium
urolithiasis. J. Urol. 130: 1115-1118 (1983).
23. Etlinger, B.: Recurrent nephrolithiasis: natural history and eect of phosphate therapy. A double-blind controlled study. Am. J. Med. 61:
200-206 (1976).
24. Coe, E. L.: Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no
metabolic disorder. Ann. intern. Med. 87: 404-410 (1977).
25. Brocas, P.; Dahl, C.; Wolf, I. L.: Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet ii: 124-125 (1981).
26. Johansson, G.; Backman, U.; Danielson, B. G.;Fellstrom, B.; Ljungball, S.; Wikstrom, B.: Biochemical and clinical eects of the prophylactic
treatment of renal calcium stones with magnesium hydroxide. J. Urol. 124: 770-774 (1980).
27. Ljungball, S.; Backman, U.; Danielson, B. G.; Fellstrom, B.; Johanson, G. Wikstrom, B.; Walinder, O.: Experiences with long-term use of
sodium cellulose phosphate for prevention of renal calcium stones: in Smith, Robertson, Finlayson, Urolithiasis: clinical and base research. pp
275-282 (Plenum Press. New York 1981).
28. Scholz, D.; Schwille, P. O.; Sigel, A.: Double-blind study with thiazide in recurrent calcium lithiasis. J. Urol. 128: 903-907 (1982).
29. Etlinger, B.; Citton, J. T.; Tang, A.; Dolman, L.; Livermore, B.: controlled studies in stone prophylaxis: comparison of placebo versus
allopurinol/chlortalidone/magnesium hydroxide: in Cohn, Potts, Fujita, Endocrine control of bone and calcium metabolism. pp. 128-129
(Elsevier, Ámsterdam 1984).
30. Ulmann, A.; Clavel, J.; Sayeg, F.: A prospective study of the ecacy on stone recurrence of water diuresis alone or associated with thiazide
or phosphate therapy: in Cohn, Potts, Fujita, Endocrine control of bone and calcium metabolism. pp. 134-135 (Elsevier, Ámsterdam 1984).
31. Wikstrom, B.; Backman, U.; Danielson, B. G.; Fellstrom, B.; Johansson, G.; Ljunghall, S.; Wide, U.: Long-term phosphate treatment in
calcium urolithiasis: in Cohn, Potts, Fujita, Endocrine control of bone and calcium metabolism. pp. 136-137 (Elsevier, Ámsterdam 1984).
32. Preminger, G. M.; Harvey, J. A.; Pak, C. Y. C.: Comparative ecacy of “specic” potassium citrate therapy vs. conservative management in
nephrolithiasis of mild-moderate severity J. Urol. 134: 658-661 (1985).
33. Pak, C. Y. C.; Sakhace, K.; Fuller, C. J.: Physiological and physicochemical prevention of calcium stone formation by potassium citrate
therapy. Trans. Ass. Am. Physns. 96: 294-305 (1983).
34. McMahon, E. G.; Ryan, J. R.; Akdamar, K.; Ertam, A.: Eect of potassium chloride supplements on upper gastrointestinal mucosa. Clin.
Pharmacol. Ther. 35: 852-855 (1984).
35. Nicar, M. J.; Hsu. M. C.; Fetner, C.: Urinary response to oral potassium citrate therapy for nephrolithiasis in a private practice setting. Clin.
Therapeutics. 8: 219-225 (1986).
36. Grith, D.: Personal communication.
Charles Y. C. Pak, MD.
Section on Mineral Metabolism.
Southwestern Medical School.
University of Texas.
Health Sciences Center at Dallas.
Dallas, TX 75235 (USA).
12